KR20120061836A - 알레르기 예방 및 치료용 프로바이오틱 유래의 비-생육가능성 물질 - Google Patents

알레르기 예방 및 치료용 프로바이오틱 유래의 비-생육가능성 물질 Download PDF

Info

Publication number
KR20120061836A
KR20120061836A KR1020127003851A KR20127003851A KR20120061836A KR 20120061836 A KR20120061836 A KR 20120061836A KR 1020127003851 A KR1020127003851 A KR 1020127003851A KR 20127003851 A KR20127003851 A KR 20127003851A KR 20120061836 A KR20120061836 A KR 20120061836A
Authority
KR
South Korea
Prior art keywords
composition
lgg
culture
supernatant
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020127003851A
Other languages
English (en)
Korean (ko)
Inventor
에릭 에이.에프. 반 톨
윌리엄 마이클 러셀
우도 헤르츠
하랄트 렌츠
홀거 가른
마흐텔트 브락스마
마리아 요안나 반 데르 워프
카린 엠. 오베르캄프
Original Assignee
미드 존슨 뉴트리션 컴파니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 미드 존슨 뉴트리션 컴파니 filed Critical 미드 존슨 뉴트리션 컴파니
Publication of KR20120061836A publication Critical patent/KR20120061836A/ko
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/38—Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/304—Foods, ingredients or supplements having a functional effect on health having a modulation effect on allergy and risk of allergy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pediatric Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1020127003851A 2009-09-11 2010-09-10 알레르기 예방 및 치료용 프로바이오틱 유래의 비-생육가능성 물질 Withdrawn KR20120061836A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09170124A EP2295535A1 (en) 2009-09-11 2009-09-11 Probiotic material
EP09170124.3 2009-09-11
PCT/NL2010/050576 WO2011031149A1 (en) 2009-09-11 2010-09-10 Probiotic derived non-viable material for allergy prevention and treatment

Publications (1)

Publication Number Publication Date
KR20120061836A true KR20120061836A (ko) 2012-06-13

Family

ID=41561153

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020127003851A Withdrawn KR20120061836A (ko) 2009-09-11 2010-09-10 알레르기 예방 및 치료용 프로바이오틱 유래의 비-생육가능성 물질

Country Status (20)

Country Link
US (1) US20110217402A1 (cg-RX-API-DMAC7.html)
EP (2) EP2295535A1 (cg-RX-API-DMAC7.html)
JP (1) JP2013504321A (cg-RX-API-DMAC7.html)
KR (1) KR20120061836A (cg-RX-API-DMAC7.html)
CN (1) CN102575224A (cg-RX-API-DMAC7.html)
AU (1) AU2010293145B2 (cg-RX-API-DMAC7.html)
BR (1) BR112012005533A2 (cg-RX-API-DMAC7.html)
CA (1) CA2772593C (cg-RX-API-DMAC7.html)
EC (1) ECSP12011786A (cg-RX-API-DMAC7.html)
ES (1) ES2614929T3 (cg-RX-API-DMAC7.html)
IN (1) IN2012DN00951A (cg-RX-API-DMAC7.html)
MX (1) MX345077B (cg-RX-API-DMAC7.html)
MY (1) MY160646A (cg-RX-API-DMAC7.html)
NZ (1) NZ597818A (cg-RX-API-DMAC7.html)
PE (1) PE20121557A1 (cg-RX-API-DMAC7.html)
PL (1) PL2475764T3 (cg-RX-API-DMAC7.html)
RU (1) RU2012114190A (cg-RX-API-DMAC7.html)
SG (1) SG178230A1 (cg-RX-API-DMAC7.html)
TW (1) TWI595090B (cg-RX-API-DMAC7.html)
WO (1) WO2011031149A1 (cg-RX-API-DMAC7.html)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130095189A1 (en) * 2011-10-14 2013-04-18 Zeina Jouni Composition and method of phytonutrients for metabolic programming effects
US20130251829A1 (en) * 2012-03-23 2013-09-26 Mead Johnson Nutrition Company Probiotic derived non-viable material for infection prevention and treatment
US9138455B2 (en) 2013-03-15 2015-09-22 Mead Johnson Nutrition Company Activating adiponectin by casein hydrolysate
US9345727B2 (en) * 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component and uses thereof
US9345741B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof
US8889633B2 (en) * 2013-03-15 2014-11-18 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof
US9289461B2 (en) 2013-03-15 2016-03-22 Mead Johnson Nutrition Company Reducing the risk of autoimmune disease
US9352020B2 (en) 2013-03-15 2016-05-31 Mead Johnson Nutrition Company Reducing proinflammatory response
US20150305384A1 (en) * 2014-04-25 2015-10-29 Mead Johnson Nutrition Company Pediatric nutritional composition with human milk oligosaccahrides, prebiotics and probiotics
MX2016015153A (es) * 2014-05-20 2017-03-07 Biogaia Ab Complementacion de microbioma neonatal.
US9730969B2 (en) 2015-11-06 2017-08-15 Mead Johnson Nutrition Company Nutritional compositions for promoting gut barrier function and ameliorating visceral pain
US10034937B2 (en) 2015-12-04 2018-07-31 Mead Johnson Nutrition Company Synergistic nutritional compositions and uses thereof
JP7057059B2 (ja) 2016-08-22 2022-04-19 株式会社明治 ラクトバチルス・プランタラムの培養物の製造方法
US20180064739A1 (en) 2016-09-06 2018-03-08 Mead Johnson Nutrition Company Nutritional composition with human milk oligosaccharides and uses thereof
US20180103675A1 (en) 2016-10-14 2018-04-19 Mead Johnson Nutrition Company Personalized pediatric nutrition products comprising human milk oligosaccharides
US10980269B2 (en) 2016-12-12 2021-04-20 Mead Johnson Nutrition Company Protein hydrolysates and methods of making same
US20180161292A1 (en) 2016-12-12 2018-06-14 Mead Johnson Nutrition Company Nutritional compositions containing butyrate and uses thereof
US20180160714A1 (en) 2016-12-12 2018-06-14 Mead Johnson Nutrition Company Nutritional compositions containing butyrate and uses thereof
US20180168215A1 (en) 2016-12-21 2018-06-21 Mead Johnson Nutrition Company Nutritional compositions containing inositol and uses thereof
US20180332881A1 (en) 2017-05-17 2018-11-22 Mead Johnson Nutrition Company Preterm infant formula containing butyrate and uses thereof
US20180333426A1 (en) 2017-05-17 2018-11-22 Mead Johnson Nutrition Company Nutritional composition with human milk oligosaccharides and uses thereof
AU2018362747B2 (en) * 2017-11-07 2025-08-14 Hubit Genomix, Inc. Method for primary prevention of allergic disorders during infancy through IgE-class-specific immunosuppression
US20190208807A1 (en) 2018-01-05 2019-07-11 Mead Johnson Nutrition Company Nutritional compositions containing milk-derived peptides and uses thereof
EP3524051A1 (en) * 2018-02-12 2019-08-14 DuPont Nutrition Biosciences ApS Matricial microencapsulation compositions
CN119040223B (zh) * 2024-11-01 2025-02-28 微康益生菌(苏州)股份有限公司 一种具有抗炎抗敏功效的鼠李糖乳酪杆菌rh22及其应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839281A (en) 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
US5407957A (en) 1990-02-13 1995-04-18 Martek Corporation Production of docosahexaenoic acid by dinoflagellates
ZA92452B (en) 1991-01-24 1992-10-28 Martek Corp Microbial oil mixtures and uses thereof
US5374567A (en) 1993-05-20 1994-12-20 The United States Of America As Represented By The Secretary Of The Navy Operational amplifier using bipolar junction transistors in silicon-on-sapphire
FI104465B (fi) * 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
US6506389B2 (en) 1995-10-20 2003-01-14 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek (Tno) Adherence factors of non pathogenic microorganisms and applications thereof for screening microorganisms for specific probiotic properties; novel pharmaceutical compositions and food additives comprising such microorganisms and adherence factors
CA2206674A1 (en) * 1996-05-30 1997-11-30 Gregor Reid Lactobacillus therapies
EP0904784A1 (en) * 1997-09-22 1999-03-31 N.V. Nutricia Probiotic nutritional preparation
WO2000071138A2 (en) * 1999-05-25 2000-11-30 Gregor Reid Oral administration of lactobacillus for the maintenance of health in women
NZ536894A (en) 2000-08-08 2006-04-28 Vialactia Bioscience Nz Ltd Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them
EP1458247B1 (en) * 2001-12-20 2014-01-22 Biolactis Inc. Malleable protein matrix and uses thereof
EP1572145A1 (en) * 2002-12-13 2005-09-14 L'oreal Use of an extract of decaffeinated coffee beans in the preparation of a composition intended to stimulate the sebaceous function of the skin by oral administration
US20040208863A1 (en) 2003-01-30 2004-10-21 James Versalovic Anti-inflammatory activity from lactic acid bacteria
ATE433674T1 (de) * 2003-06-23 2009-07-15 Nestec Sa Säuglingsnährpräparat oder folgemilch
JP2008501316A (ja) 2004-04-20 2008-01-24 ザ ユニヴァーシティー オヴ シカゴ ラクトバシルスｇｇ由来プロバイオティック化合物及びそれらの使用
US20100233312A9 (en) * 2005-04-11 2010-09-16 The Procter & Gamble Company Compositions comprising probiotic and sweetener components
US20060233772A1 (en) * 2005-04-15 2006-10-19 Udo Herz Method for preventing or treating the development of respiratory allergies
US7303745B2 (en) * 2005-04-15 2007-12-04 Bristol-Myers Squibb Company Method for preventing or treating the development of respiratory allergies
US9133249B2 (en) * 2006-10-24 2015-09-15 Vanderbilt University Compositions and methods for the treatment of disorders involving epithelial cell apoptosis
JP2010523695A (ja) * 2007-04-11 2010-07-15 アルコン リサーチ， リミテッド アレルギー性鼻炎およびアレルギー性結膜炎を処置するためのＴＮＦαのインヒビターおよび抗ヒスタミン薬の使用
WO2009137159A2 (en) * 2008-04-17 2009-11-12 Trustees Of Dartmouth College Bioactive molecules produced by probiotic bacteria and methods for isolating and using the same

Also Published As

Publication number Publication date
SG178230A1 (en) 2012-03-29
EP2475764B1 (en) 2016-12-14
EP2475764A1 (en) 2012-07-18
ES2614929T3 (es) 2017-06-02
TWI595090B (zh) 2017-08-11
JP2013504321A (ja) 2013-02-07
IN2012DN00951A (cg-RX-API-DMAC7.html) 2015-04-10
US20110217402A1 (en) 2011-09-08
EP2295535A1 (en) 2011-03-16
TW201124529A (en) 2011-07-16
RU2012114190A (ru) 2013-10-20
ECSP12011786A (es) 2012-07-31
PE20121557A1 (es) 2012-11-21
BR112012005533A2 (pt) 2016-04-26
CA2772593C (en) 2018-11-27
CA2772593A1 (en) 2011-03-17
MX2012002716A (es) 2012-04-19
MX345077B (es) 2017-01-16
PL2475764T3 (pl) 2017-06-30
AU2010293145A1 (en) 2012-03-08
AU2010293145B2 (en) 2016-04-14
MY160646A (en) 2017-03-15
CN102575224A (zh) 2012-07-11
WO2011031149A1 (en) 2011-03-17
NZ597818A (en) 2014-01-31

Similar Documents

Publication Publication Date Title
AU2010293145B2 (en) Probiotic derived non-viable material for allergy prevention and treatment
EP3010521B1 (en) Synbiotic composition for treatment of infections in allergic patients
CN103763940B (zh) 促进有益微生物群生长的益生菌和人乳寡糖的合益素组合
AU2013235365B2 (en) Probiotic derived non-viable material for infection prevention and treatment
US20100063002A1 (en) Method of improving skills with a composition comprising non-digestible saccharide
CN105722409A (zh) 用于预防或治疗婴儿和幼儿的坏死性小肠结肠炎的组合物
RU2744199C2 (ru) Композиция, содержащая олигосахариды грудного молока, применяемая для младенцев или детей младшего возраста в целях профилактики или лечения аллергических реакций
SG172094A1 (en) Prevention and treatment of rotavirus diarrhoea
US20170360855A1 (en) Nutritional compositions for promoting gut barrier function and ameliorating visceral pain
RU2724536C2 (ru) Ферментированная молочная смесь с неперевариваемыми олигосахаридами
US20250144176A1 (en) Compositions comprising osteopontin (opn)
CN108697141A (zh) 含有不可消化寡糖和非复制型产乳酸细菌的营养配方物
EP4440339B1 (en) Nutritional composition for improving infant microbiota
HK1172928A (en) Probiotic derived non-viable material for allergy prevention and treatment
Mazzola et al. Infant Development, Currently the Main Applications of Probiotics And Prebiotics?
HK1262095A1 (en) Probiotic derived non-viable material for infection prevention and treatment
HK1242227A1 (en) Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20120214

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
N231 Notification of change of applicant
PN2301 Change of applicant

Patent event date: 20130604

Comment text: Notification of Change of Applicant

Patent event code: PN23011R01D

A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20150813

Comment text: Request for Examination of Application

PC1202 Submission of document of withdrawal before decision of registration

Comment text: [Withdrawal of Procedure relating to Patent, etc.] Withdrawal (Abandonment)

Patent event code: PC12021R01D

Patent event date: 20160315